Table of Contents

Executive Summary

1 Industry Overview of Anti - Neoplastic Agents

• 1.1 Definition of Anti - Neoplastic Agents
• 1.2 Anti - Neoplastic Agents Segment by Type
  • 1.2.1 Global Anti - Neoplastic Agents Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Chemotherapy
  • 1.2.3 Targeted Therapy
  • 1.2.4 Immunotherapy
  • 1.2.5 Hormonal Therapy (Biologic Therapy)
  • 1.2.6 Others
• 1.3 Anti - Neoplastic Agents Segment by Applications
  • 1.3.1 Global Anti - Neoplastic Agents Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Respiratory/Lung Cancer
  • 1.3.7 Other Cancers
• 1.4 Global Anti - Neoplastic Agents Overall Market
  • 1.4.1 Global Anti - Neoplastic Agents Revenue (2014-2025)
  • 1.4.2 Global Anti - Neoplastic Agents Production (2014-2025)
  • 1.4.3 North America Anti - Neoplastic Agents Status and Prospect (2014-2025)
  • 1.4.4 Europe Anti - Neoplastic Agents Status and Prospect (2014-2025)
  • 1.4.5 China Anti - Neoplastic Agents Status and Prospect (2014-2025)
  • 1.4.6 Japan Anti - Neoplastic Agents Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Anti - Neoplastic Agents Status and Prospect (2014-2025)
  • 1.4.8 India Anti - Neoplastic Agents Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Anti - Neoplastic Agents
• 2.3 Manufacturing Process Analysis of Anti - Neoplastic Agents
• 2.4 Industry Chain Structure of Anti - Neoplastic Agents

3 Development and Manufacturing Plants Analysis of Anti - Neoplastic Agents

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Anti - Neoplastic Agents Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Anti - Neoplastic Agents
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Anti - Neoplastic Agents Production and Capacity Analysis
• 4.2 Anti - Neoplastic Agents Revenue Analysis
• 4.3 Anti - Neoplastic Agents Price Analysis
• 4.4 Market Concentration Degree

5 Anti - Neoplastic Agents Regional Market Analysis

• 5.1 Anti - Neoplastic Agents Production by Regions
  • 5.1.1 Global Anti - Neoplastic Agents Production by Regions
  • 5.1.2 Global Anti - Neoplastic Agents Revenue by Regions
• 5.2 Anti - Neoplastic Agents Consumption by Regions
• 5.3 North America Anti - Neoplastic Agents Market Analysis
  • 5.3.1 North America Anti - Neoplastic Agents Production
  • 5.3.2 North America Anti - Neoplastic Agents Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Anti - Neoplastic Agents Import and Export
• 5.4 Europe Anti - Neoplastic Agents Market Analysis
  • 5.4.1 Europe Anti - Neoplastic Agents Production
  • 5.4.2 Europe Anti - Neoplastic Agents Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Anti - Neoplastic Agents Import and Export
• 5.5 China Anti - Neoplastic Agents Market Analysis
  • 5.5.1 China Anti - Neoplastic Agents Production
  • 5.5.2 China Anti - Neoplastic Agents Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Anti - Neoplastic Agents Import and Export
• 5.6 Japan Anti - Neoplastic Agents Market Analysis
  • 5.6.1 Japan Anti - Neoplastic Agents Production
  • 5.6.2 Japan Anti - Neoplastic Agents Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Anti - Neoplastic Agents Import and Export
• 5.7 Southeast Asia Anti - Neoplastic Agents Market Analysis
  • 5.7.1 Southeast Asia Anti - Neoplastic Agents Production
  • 5.7.2 Southeast Asia Anti - Neoplastic Agents Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Anti - Neoplastic Agents Import and Export
• 5.8 India Anti - Neoplastic Agents Market Analysis
  • 5.8.1 India Anti - Neoplastic Agents Production
  • 5.8.2 India Anti - Neoplastic Agents Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Anti - Neoplastic Agents Import and Export

6 Anti - Neoplastic Agents Segment Market Analysis (by Type)

• 6.1 Global Anti - Neoplastic Agents Production by Type
• 6.2 Global Anti - Neoplastic Agents Revenue by Type
• 6.3 Anti - Neoplastic Agents Price by Type

7 Anti - Neoplastic Agents Segment Market Analysis (by Application)

• 7.1 Global Anti - Neoplastic Agents Consumption by Application
• 7.2 Global Anti - Neoplastic Agents Consumption Market Share by Application (2014-2019)

8 Anti - Neoplastic Agents Major Manufacturers Analysis

• 8.1 Roche
  • 8.1.1 Roche Anti - Neoplastic Agents Production Sites and Area Served
  • 8.1.2 Roche Product Introduction, Application and Specification
  • 8.1.3 Roche Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis
  • 8.2.1 Novartis Anti - Neoplastic Agents Production Sites and Area Served
  • 8.2.2 Novartis Product Introduction, Application and Specification
  • 8.2.3 Novartis Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Celgene
  • 8.3.1 Celgene Anti - Neoplastic Agents Production Sites and Area Served
  • 8.3.2 Celgene Product Introduction, Application and Specification
  • 8.3.3 Celgene Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bristol-Myers Squibb
  • 8.4.1 Bristol-Myers Squibb Anti - Neoplastic Agents Production Sites and Area Served
  • 8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.4.3 Bristol-Myers Squibb Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Amgen
  • 8.5.1 Amgen Anti - Neoplastic Agents Production Sites and Area Served
  • 8.5.2 Amgen Product Introduction, Application and Specification
  • 8.5.3 Amgen Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Johnson & Johnson
  • 8.6.1 Johnson & Johnson Anti - Neoplastic Agents Production Sites and Area Served
  • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.6.3 Johnson & Johnson Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Pfizer
  • 8.7.1 Pfizer Anti - Neoplastic Agents Production Sites and Area Served
  • 8.7.2 Pfizer Product Introduction, Application and Specification
  • 8.7.3 Pfizer Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Takeda
  • 8.8.1 Takeda Anti - Neoplastic Agents Production Sites and Area Served
  • 8.8.2 Takeda Product Introduction, Application and Specification
  • 8.8.3 Takeda Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Eli Lilly
  • 8.9.1 Eli Lilly Anti - Neoplastic Agents Production Sites and Area Served
  • 8.9.2 Eli Lilly Product Introduction, Application and Specification
  • 8.9.3 Eli Lilly Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 AstraZeneca
  • 8.10.1 AstraZeneca Anti - Neoplastic Agents Production Sites and Area Served
  • 8.10.2 AstraZeneca Product Introduction, Application and Specification
  • 8.10.3 AstraZeneca Anti - Neoplastic Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Astellas
• 8.12 Merck & Co.
• 8.13 Sanofi
• 8.14 Bayer
• 8.15 Biogen Idec
• 8.16 Eisai
• 8.17 Teva
• 8.18 Otsuka
• 8.19 Merck KGaA
• 8.20 Ipsen
• 8.21 AbbVie
• 8.22 Gilead Sciences

9 Development Trend of Analysis of Anti - Neoplastic Agents Market

• 9.1 Global Anti - Neoplastic Agents Market Trend Analysis
  • 9.1.1 Global Anti - Neoplastic Agents Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Anti - Neoplastic Agents Regional Market Trend
  • 9.2.1 North America Anti - Neoplastic Agents Forecast 2019-2025
  • 9.2.2 Europe Anti - Neoplastic Agents Forecast 2019-2025
  • 9.2.3 China Anti - Neoplastic Agents Forecast 2019-2025
  • 9.2.4 Japan Anti - Neoplastic Agents Forecast 2019-2025
  • 9.2.5 Southeast Asia Anti - Neoplastic Agents Forecast 2019-2025
  • 9.2.6 India Anti - Neoplastic Agents Forecast 2019-2025
• 9.3 Anti - Neoplastic Agents Market Trend (Product Type)
• 9.4 Anti - Neoplastic Agents Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Anti - Neoplastic Agents Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

The global Anti - Neoplastic Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti - Neoplastic Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti - Neoplastic Agents market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti - Neoplastic Agents in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti - Neoplastic Agents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others

Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers